These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 14588127

  • 1. Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer.
    Meiser B, Butow P, Price M, Bennett B, Berry G, Tucker K, National Consortium for Research into Familial Breast Cancer Psychological Group.
    J Womens Health (Larchmt); 2003 Oct; 12(8):769-78. PubMed ID: 14588127
    [Abstract] [Full Text] [Related]

  • 2. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer.
    Meiser B, Butow P, Barratt A, Friedlander M, Gattas M, Kirk J, Suthers G, Walpole I, Tucker K.
    Gynecol Oncol; 1999 Oct; 75(1):122-9. PubMed ID: 10502438
    [Abstract] [Full Text] [Related]

  • 3. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A, Peterson SK, Erlichman J, Broglio K, Yekell S, Schmeler K, Lu K, Meric-Bernstam F, Amos C, Strong L, Arun B.
    Cancer; 2006 Dec 15; 107(12):2745-51. PubMed ID: 17109443
    [Abstract] [Full Text] [Related]

  • 4. Predictors of and satisfaction with bilateral prophylactic mastectomy.
    Stefanek ME, Helzlsouer KJ, Wilcox PM, Houn F.
    Prev Med; 1995 Jul 15; 24(4):412-9. PubMed ID: 7479633
    [Abstract] [Full Text] [Related]

  • 5. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction.
    Isern AE, Tengrup I, Loman N, Olsson H, Ringberg A.
    J Plast Reconstr Aesthet Surg; 2008 Oct 15; 61(10):1177-87. PubMed ID: 17938010
    [Abstract] [Full Text] [Related]

  • 6. Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer.
    Antill Y, Reynolds J, Young MA, Kirk J, Tucker K, Bogtstra T, Wong S, Dudding T, Di Iulio J, Phillips KA.
    Eur J Cancer; 2006 Mar 15; 42(5):621-8. PubMed ID: 16434187
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
    Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB.
    N Engl J Med; 1999 Jan 14; 340(2):77-84. PubMed ID: 9887158
    [Abstract] [Full Text] [Related]

  • 8. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
    Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van 't Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL.
    J Clin Oncol; 2004 Mar 15; 22(6):1055-62. PubMed ID: 14981104
    [Abstract] [Full Text] [Related]

  • 9. Interest in breast cancer chemoprevention among older women.
    Tjia J, Micco E, Armstrong K.
    Breast Cancer Res Treat; 2008 Apr 15; 108(3):435-53. PubMed ID: 17554628
    [Abstract] [Full Text] [Related]

  • 10. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices.
    Geiger AM, Yu O, Herrinton LJ, Barlow WE, Harris EL, Rolnick S, Barton MB, Elmore JG, Fletcher SW.
    Arch Intern Med; 2005 Mar 14; 165(5):516-20. PubMed ID: 15767526
    [Abstract] [Full Text] [Related]

  • 11. Physicians' attitudes towards mammography and prophylactic surgery for hereditary breast/ovarian cancer risk and subsequently published guidelines.
    Julian-Reynier C, Eisinger F, Moatti JP, Sobol H.
    Eur J Hum Genet; 2000 Mar 14; 8(3):204-8. PubMed ID: 10780786
    [Abstract] [Full Text] [Related]

  • 12. Quality of life after bilateral prophylactic mastectomy.
    Geiger AM, Nekhlyudov L, Herrinton LJ, Rolnick SJ, Greene SM, West CN, Harris EL, Elmore JG, Altschuler A, Liu IL, Fletcher SW, Emmons KM.
    Ann Surg Oncol; 2007 Feb 14; 14(2):686-94. PubMed ID: 17103066
    [Abstract] [Full Text] [Related]

  • 13. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
    Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, Foulkes WD, Domchek S, Ainsworth P, Isaacs C, Tung N, Gronwald J, Cummings S, Wagner T, Manoukian S, Møller P, Weitzel J, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group.
    J Clin Oncol; 2008 Mar 01; 26(7):1093-7. PubMed ID: 18195327
    [Abstract] [Full Text] [Related]

  • 14. Inherited genetic susceptibility to breast cancer.
    Chang-Claude J.
    IARC Sci Publ; 2001 Mar 01; 154():177-90. PubMed ID: 11220657
    [Abstract] [Full Text] [Related]

  • 15. Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.
    Melnikow J, Paterniti D, Azari R, Kuenneth C, Birch S, Kuppermann M, Nuovo J, Keyzer J, Henderson S.
    Cancer; 2005 May 15; 103(10):1996-2005. PubMed ID: 15825209
    [Abstract] [Full Text] [Related]

  • 16. Acceptance for preventive genetic testing and prophylactic surgery in women with a family history of breast and gynaecological cancers.
    Ackermann S, Lux MP, Fasching PA, Strissl P, Renner SP, Poehls U, Bender HG, Beckmann MW.
    Eur J Cancer Prev; 2006 Dec 15; 15(6):474-9. PubMed ID: 17106324
    [Abstract] [Full Text] [Related]

  • 17. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations.
    Fatouros M, Baltoyiannis G, Roukos DH.
    Ann Surg Oncol; 2008 Jan 15; 15(1):21-33. PubMed ID: 17940826
    [Abstract] [Full Text] [Related]

  • 18. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT.
    Gynecol Oncol; 2005 May 15; 97(2):457-67. PubMed ID: 15863145
    [Abstract] [Full Text] [Related]

  • 19. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
    Tiller K, Meiser B, Gould L, Tucker K, Dudding T, Franklin J, Friedlander M, Andrews L.
    Psychooncology; 2005 Apr 15; 14(4):249-61. PubMed ID: 15386771
    [Abstract] [Full Text] [Related]

  • 20. Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005.
    McLaughlin CC, Lillquist PP, Edge SB.
    Cancer; 2009 Dec 01; 115(23):5404-12. PubMed ID: 19787635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.